Antibiotic Susceptibility of Black-Pigmented \u3cem\u3eBacteroides\u3c/em\u3e Isolates from the Human Oral Cavity by Laatsch, Linda Jean et al.
Marquette University
e-Publications@Marquette
Biomedical Sciences Faculty Research and
Publications Biomedical Sciences, Department of
10-1-1982
Antibiotic Susceptibility of Black-Pigmented
Bacteroides Isolates from the Human Oral Cavity
Linda Jean Laatsch
Marquette University
Paul R. Hohenfeldt
Marquette University
William L. Kos
Marquette University, william.kos@marquette.edu
Published version. Antimicrobial Agents and Chemotherapy, Vol. 22, No. 4 (October 1982): 698-700.
DOI. © 1982 American Society for Microbiology. Used with permission.
Vol. 22, No. 4ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, OCt. 1982, p. 698-700
0066-4804/82/100698-03$02.00/0
Copyright 0 1982, American Society for Microbiology
Antibiotic Susceptibility of Black-Pigmented Bacteroides
Isolates from the Human Oral Cavity
LINDA J. LAATSCH,l* PAUL R. HOHENFELDT,2 AND WILLIAM L. KOS3
Departments of Endodontics2 and Basic Sciences,3 School of Dentistry, and Program in Medical
Technology,1 Marquette University, Milwaukee, Wisconsin 53233
Received 3 May 1982/Accepted 22 July 1982
The minimal inhibitory concentrations of penicillin and six other antibiotics
were determined for 66 oral black-pigmented Bacteroides isolates by using the
National Committee for Clinical Laboratory Standards proposed standard agar
dilution technique. These results plus iodometric determination of j-lactamase
activity showed that oral isolates of black-pigmented Bacteroides are remaining
relatively susceptible to commonly used antibiotics.
The black-pigmented Bacteroides species
(BPB) (B. melaninogenicus and B. asaccharoly-
ticus) are commonly found as normal flora in the
human intestinal and reproductive tracts and in
the oral cavity (3). Their incidence within the
oral cavity seems to increase with the eruption
of permanent teeth (13), and, along with other
normal oral flora, they are characteristically
involved in endodontic as well as periodontic
infections (4, 13).
The significance of B. melaninogenicus in
endodontic infections was first shown in 1976 by
Sundqvist, who studied the microbial flora of
teeth with pulpal necrosis (G. Sundqvist, Umea
University Odontological Dissertation, Umea,
Sweden, 1976). He found that only those teeth
with periapical destruction contained bacteria
and that symptoms of acute periapical inflamma-
tion were present only in teeth containing B.
melaninogenicus as part of the microbial flora.
Griffee et al. in 1980 demonstrated a similar
relationship between periapical symptoms and
the presence of B. melaninogenicus (4).
Penicillin has traditionally been the recom-
mended chemotherapy for most infections in-
volving BPB. However, a number of recent
studies have suggested an increasing.resistance
of these organisms to penicillin and to other
commonly prescribed antibiotics (1, 2, 5, 6, 8,
10). Although this has aroused concern among
dental clinicians, it cannot be determined from
these studies whether BPB present as part of the
normal oral microflora show similar patterns of
increasing resistance. These studies were con-
ducted in hospital laboratories and evaluated
antibiotic susceptibilities of BPB isolates origi-
nating from a variety of unspecified body sites
and clinical specimens. Only the study of Nie-
derau et al. (8) included oral isolates, but the
number of isolates tested was small (n = 10).
The purpose of our study was to determine the
antibiotic susceptibility of oral isolates of BPB
from healthy mouths. These data will aid in
establishing a protocol for therapy since these
isolates are constituents of the normal oral flora
and it is this normal flora which serves as the
source of pulpal, periapical, and periodontal
infections.
A total of 66 BPB isolates were obtained from
specimens of subgingival plaque collected from
freshman dental students (n = 9) and patients
seen in the dental hygiene clinic (n = 53) at the
Marquette University School of Dentistry, Mil-
waukee, Wis., as well as from pulps of patients
undergoing endodontic therapy in private prac-
tice (n = 4). Since the results did not reveal any
significant differences in the antibiotic suscepti-
bility of these isolates, no distinction between
the groups is made below.
Plaque specimens were collected into reduced
thioglycollate medium without indicator (Difco
Laboratories, Detroit, Mich.) and dispersed by
shaking with a glass bead. Each broth was
inoculated onto a brain heart infusion agar plate
(Difco) supplemented with 0.5% yeast extract
(Difco), 1% IsoVitaleX (BBL Microbiology Sys-
tems, Cockeysville, Md.), 0.5 p.g of vitamin K
(Sigma Chemical Co., St. Louis, Mo.) per ml,
0.5 ,ug of hemin (Sigma) per ml, and 5% laked
sheep blood (GIBCO Diagnostics, Madison,
Wis.). The plates were incubated anaerobically
at 35 to 37°C for 5 to 7 days with the GasPak
System (BBL). Colonies that produced brown to
black pigmentation were subcultured to two
supplemented brain heart infusion agar plates.
One was incubated anaerobically, and the other
was incubated aerobically in an atmosphere of 5
to 10o C02. Isolates were identified as members
of the B. melaninogenicus-B. asaccharolyticus
group if they produced a brown to black pigment
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on the anaerobic plate, were incapable of growth
on the aerobic plate, appeared as gram-negative
bacilli or coccobacilli upon staining, and showed
a positive immunofluorescent reaction with the
Fluoretec-M kit (General Diagnostics, Warner-
Lambert Co., Morris Plains, N.J.). Previous
studies have shown that the Fluoretec-M kit is a
reliable method for identifying B. melaninogeni-
cus and B. asaccharolyticus (12).
The following antibiotics were used in testing:
erythromycin, cephalexin, and potassium peni-
cillin G (Eli Lilly & Co., Indianapolis, Ind.);
clindamycin hydrochloride (The Upjohn Co.,
Kalamazoo, Mich.); tetracycline hydrochloride
and chloramphenicol (Sigma); and ampicillin
(Bristol Laboratories, Syracuse, N.Y.). Appro-
priate stock solutions of each antibiotic were
prepared in sterile water and stored at -20°C for
not more than 1 week before use.
Antibiotic susceptibility testing was per-
formed according to the National Committee for
Clinical Laboratory Standards proposed stan-
dard agar dilution procedure (7). Anaerobic and
aerobic growth control plates without antibiotic
were included in each experiment. Due to the
fastidious nature of the BPB, we found it neces-
sary to add rabbit serum (GIBCO Laboratories,
Grand Island, N.Y.) to a 5% concentration to
the thioglycollate medium and to Wilkins Chal-
gren agar (Difco). Preliminary experiments
showed that this enhanced the growth and re-
covery of BPB without changing the acceptable
range of minimal inhibitory concentration (MIC)
values required for the control cultures.
The Wilkins Chalgren agar plates were incu-
bated anaerobically at 35 to 37°C for 48 h. The
MIC for each isolate was defined as the lowest
concentration of antibiotic yielding no growth or
a barely visible haze of growth.
The 1-lactamase test was performed on 41
isolates according to the rapid iodometric meth-
od (11). Known positive and negative control
strains were assayed simultaneously. This meth-
od was chosen instead of the chromogenic ceph-
alosporin method since 1-lactamases of BPB are
more active against penicillin than against ceph-
alothin (9).
The results of the agar dilution susceptibility
tests are shown in Table 1. The MIC values of
chloramphenicol, cindamycin, penicillin G, and
tetracycline for control cultures of Clostridium
perfringens (ATCC 13124) and Bacteroides the-
taiotaomicron (ATCC 29741) fell within the ac-
ceptable range (mode MIC + one dilution). MIC
values of the other antibiotics tested have not
been established for the control strains in the
proposed standard.
We found that 90%o of our BPB isolates were
inhibited by penicillin G at 0.5 U/ml or ampicillin
at 0.5 p,g/ml. The six isolates which had penicil-
TABLE 1. Inhibitory activity of antibiotics against
oral isolates of BPB
MIC (,ug/ml)°
Antibiotic Rmgeb For 50% For 90%oRange inhibition inhibition
Penicillin G <0.125-8 <0.125 0.5
Ampicillin <0.125-4 <0.125 0.5
Tetracycline <0.125-16 <0.125 4
Cephalexin <0.125-16 0.25 0.5
Erythromycin '0.125-1 <0.125 0.25
Clindamycin <0.125 0.125 <0.125
Chloramphenicol 0.5-2 1 1
a Penicillin G MICs are expressed as units per
milliliter.
b Number of isolates (n) = 66 for all antibiotics
except clindamycin, for which n = 52.
lin MIC values of >0.5 U/ml also had ampicillin
MIC values of >0.5 ,ug/ml. In contrast, recent
studies of isolates of unspecified, presumably
nonoral, origin have found that penicillin and
ampicillin levels from 4 to >64 U or p.g/ml were
required for 90%o inhibition (1, 2, 5, 6, 10; K. E.
Aldridge, C. V. Sanders, and R. L. Marier,
Abstr. Annu. Meet. Am. Soc. Microbiol. 1981,
C21, p. 266). Only the very recent study by
Sutter et al. (V. L. Sutter, M. J. Jones, and
A. T. Ghoneim, Abstr. Annu. Meet. Am. Soc.
Microbiol. 1982, A18, p. 4) reports data similar
to ours. Using isolates from periodontitis pa-
tients, Sutter et al. found that 90o of their BPB
isolates were inhibited by penicillin G at 0.5 U/
ml, with a few strains requiring >32 U/ml for
inhibition.
A total of 41 of our isolates were tested for ,-
lactamase production. These included 37 iso-
lates with penicillin MIC values of c0.5 U/ml
and 4 isolates with penicillin MIC values of 4 to 8
U/ml. All isolates with penicillin MICs of s0.5
U/ml were negative for 1-lactamase, whereas
those with penicillin MICs of 4 to 8 U/ml were
positive. In contrast to Murray and Rosenblatt,
who found 56% of their clinical isolates to be 1B-
lactamase producing (6), only 10% of our oral
isolates tested exhibited this activity. The clini-
cal significance of this enzyme in anaerobes,
however, is still questionable.
Ninety percent of our isolates were inhibited
by tetracycline at 4 tjg/ml. Studies from 1977 and
1980 reported only 40 to 50% inhibition of BPB
at this concentration (2, 6). We also found that
cephalexin at 0.5 ,ug/ml was sufficient to produce
90%o inhibition. This contrasts greatly with the
report of Niederau at al., who found that cepha-
lexin at 25 ,ug/ml was necessary for 90%o inhibi-
tion (8). Additionally, only Niederau et al. have
demonstrated increased resistance to chloram-
phenicol, finding that 25 ,ug/ml was needed for
90% inhibition. No other studies, including ours,
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have reported increasing resistance to this anti-
biotic. Likewise, no studies have shown the
BPB to be developing resistance to clindamycin
or erythromycin, regardless of the source or
nature of the specimen.
Our data indicate that oral isolates of BPB are
remaining relatively susceptible to penicillin and
other antibiotics. Other authors have suggested
that their increased isolation of resistant strains
may have been due to extensive antibiotic use at
their hospitals (1, 2). This may account for our
isolation of highly susceptible BPB, since our
isolates were derived from patients who were
not recently hospitalized. Even patients with
endodontic and periodontic infections would be
treated as outpatients. Our patient population
was derived from a broad range of age and
socioeconomic groups; therefore we feel that
resistant strains were not missed as a result of
evaluating a limited or perhaps biased sample.
The increasing isolation rate of antibiotic-
resistant strains from clinical specimens may or
may not foretell an increasing incidence among
the normal oral microflora. Our results suggest
that data generated in clinical laboratories may
not be applicable to endodontic and periodontic
patients or outpatient groups. Periodic monitor-
ing of the susceptibility patterns of oral microor-
ganisms may be appropriate and yield useful
data for the dental clinician and oral surgeon in
the form of a more up-to-date protocol for
therapy.
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